Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 50.65
+0.05 (0.10%)
Apr 2, 2025, 2:45 PM CST
Cathay Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | - | 366.52 | 553.27 | 594.72 | 457.67 | Upgrade
|
| Depreciation & Amortization | - | 280.95 | 265.12 | 168.54 | 118.32 | Upgrade
|
| Other Amortization | - | 8.65 | 4.68 | 3.68 | 2.27 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.01 | -0.05 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 27.65 | 36.22 | 10.69 | 12.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 7.82 | 3.71 | -16.3 | -27.97 | Upgrade
|
| Other Operating Activities | - | 47.9 | -3.57 | 25.36 | 24.35 | Upgrade
|
| Change in Accounts Receivable | - | -320.06 | 24.8 | -224.95 | -25.54 | Upgrade
|
| Change in Inventory | - | 78.3 | -418.06 | -282.62 | -90.45 | Upgrade
|
| Change in Accounts Payable | - | 133.66 | 355.46 | 310.02 | 33.28 | Upgrade
|
| Change in Other Net Operating Assets | - | 8.65 | 18.18 | 6.47 | 5.35 | Upgrade
|
| Operating Cash Flow | - | 569.45 | 803.67 | 578.69 | 514.96 | Upgrade
|
| Operating Cash Flow Growth | - | -29.14% | 38.88% | 12.37% | 43.20% | Upgrade
|
| Capital Expenditures | - | -1,570 | -4,198 | -1,459 | -763.11 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 142.01 | 0.14 | - | - | Upgrade
|
| Investment in Securities | - | -101.04 | - | 1,320 | -470 | Upgrade
|
| Other Investing Activities | - | -30 | - | 28.42 | 35.88 | Upgrade
|
| Investing Cash Flow | - | -1,559 | -4,198 | -110.76 | -1,197 | Upgrade
|
| Long-Term Debt Issued | - | 937.02 | 1,126 | 798.08 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -300.24 | Upgrade
|
| Long-Term Debt Repaid | - | -289.77 | -740 | -55 | - | Upgrade
|
| Total Debt Repaid | - | -289.77 | -740 | -55 | -300.24 | Upgrade
|
| Net Debt Issued (Repaid) | - | 647.25 | 386.47 | 743.08 | -300.24 | Upgrade
|
| Issuance of Common Stock | - | 4.17 | 4.52 | - | 6,661 | Upgrade
|
| Repurchase of Common Stock | - | -31.52 | -94.67 | - | - | Upgrade
|
| Common Dividends Paid | - | -137.75 | -206.85 | -339.63 | -3.87 | Upgrade
|
| Dividends Paid | - | -137.75 | -206.85 | -339.63 | -3.87 | Upgrade
|
| Other Financing Activities | - | -744.31 | 314.41 | 2,584 | -293.06 | Upgrade
|
| Financing Cash Flow | - | -262.16 | 403.88 | 2,987 | 6,063 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 40.22 | 59.98 | -9.19 | -2.83 | Upgrade
|
| Net Cash Flow | - | -1,211 | -2,931 | 3,446 | 5,378 | Upgrade
|
| Free Cash Flow | - | -1,000 | -3,395 | -880.49 | -248.15 | Upgrade
|
| Free Cash Flow Margin | - | -47.32% | -139.06% | -37.25% | -16.57% | Upgrade
|
| Free Cash Flow Per Share | - | -1.72 | -5.83 | -1.51 | -0.46 | Upgrade
|
| Cash Income Tax Paid | - | 90.88 | -281.56 | -12.97 | 36 | Upgrade
|
| Levered Free Cash Flow | - | -567.98 | -3,302 | -1,301 | -673.57 | Upgrade
|
| Unlevered Free Cash Flow | - | -547.87 | -3,290 | -1,290 | -671.16 | Upgrade
|
| Change in Net Working Capital | - | -622.24 | -368.28 | 321.72 | 308.6 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.